CD44 and gastric cancer: To confirm whether EGFR inhibition-mediated CD44v downregulation could cause the CD44v9-expressing cell-selective growth inhibition, we examined the effect of CD44 knockdown on the proliferation of CD44v9-positive and CD44v9-negative cells sorted from the gastric cancer PDCs (Fig. 4d).